Sugi Predict

Sugi Predict / Compounds / SCHEMBL29378690

SCHEMBL29378690

SCHEMBL29378690

Cc1cc(C)cc(P(c2cc(C)cc(C)c2)c2ccc3ccccc3c2-c2c(P(c3cc(C)cc(C)c3)c3cc(C)cc(C)c3)ccc3ccccc23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 6/20 0.41
▸ CYP1A2 P05177 5/20 0.41
▸ MAPT P10636 2/20 0.39
▸ TSHR P16473 3/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ HSD17B10 Q99714 4/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ HIF1A Q16665 2/20 0.38
▸ CYP1B1 Q16678 2/20 0.38
▸ HPGD P15428 3/20 0.37
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HPRT1 P00492 1/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CYP1A1 P04798 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29122 1.00 CYP2A6 (0.41) CYP2A6CYP1A2MAPTTSHRALDH1A1
SCHEMBL31462816 1.00 CYP2A6 (0.41) CYP2A6CYP1A2MAPTTSHRALDH1A1
SCHEMBL28433701 0.98 CYP2A6 (0.40) CYP2A6CYP1A2MAPTTSHRALDH1A1
SCHEMBL7590618 0.91 MAPT (0.43) CYP2A6CYP1A2MAPTHSD17B10TDP1
SCHEMBL5080119 0.89 DHFR (0.40) CYP2A6CYP1A2MAPTTSHRALDH1A1
SCHEMBL7568810 0.88 HSD17B10 (0.40) CYP2A6CYP1A2TSHRALDH1A1HSD17B10
SCHEMBL1042470 0.86 CYP2A6 (0.42) CYP2A6CYP1A2MAPTTSHRALDH1A1
SCHEMBL31566350 0.86 CYP2A6 (0.42) CYP2A6CYP1A2MAPTTSHRALDH1A1
SCHEMBL23943725 0.86 CYP2A6 (0.38) CYP2A6CYP1A2MAPTTSHRALDH1A1
SCHEMBL29424786 0.86 MAPT (0.38) CYP2A6CYP1A2MAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010689-A Preparation method of cycloparaffin 浙江清华长三角研究院 2026-05-12 — — CN claimed
EP-3710422-B1 PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES SYNGENTA CROP PROTECTION AG (CH) 2026-01-07 — — EP claimed
EP-4330229-B1 METHOD FOR PRODUCING PYRROLIDINE COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2025-12-17 — — EP claimed
CN-120118068-A Chemical process for preparing phenylpiperidinyl indole derivatives 诺华股份有限公司 2025-06-10 — — CN claimed
WO-2025096445-A1 SYNTHESIS OF INTERMEDIATES FOR THE PREPARATION OF MACROCYCLIC COMPOUNDS ALKERMES, INC. (US) 2025-05-08 — — WO claimed
EP-3856738-B1 PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST QUIM SINTETICA S A (ES) 2025-03-19 — — EP claimed
US-20240279248-A1 SYNTHESIS OF BORONATE ESTER DERIVATIVES AND USES THEREOF MELINTA SUBSIDIARY CORP. 2024-08-22 — — US claimed
CN-118420493-A Preparation method of 2, 5-disubstituted aminocaproate ester and method for preparing Li Texi tenib by using preparation method 山东福长药业有限公司 2024-08-02 — — CN claimed
CN-118388347-A Compound, borate derivative formed from compound and preparation method of borate derivative 梅琳塔治疗公司 2024-07-26 — — CN claimed
US-20240228437-A1 METHOD FOR PRODUCING PYRROLIDINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-07-11 — — US claimed
US-20240002400-A1 ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES AMGEN INC. (US) 2024-01-04 — — US claimed
CN-113845478-B Intermediate, and preparation method and application thereof 四川大学 2023-11-21 — — CN claimed
EP-4251604-A1 ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES Amgen Inc. (US) 2023-10-04 — — EP claimed
CN-111417618-B Process for preparing enantiomerically and diastereomerically enriched cyclobutane amines and amides 先正达参股股份有限公司 2023-06-30 — — CN claimed
US-11465977-B2 Process for the preparation of sphingosine-1-phosphate receptor agonist Química Sintética, S.A. (ES) 2022-10-11 — — US claimed
CN-110312713-B Process for preparing tetrahydrocarbazole carboxamide compounds 百时美施贵宝公司 2022-08-12 — — CN claimed
WO-2022127320-A1 INTERMEDIATE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 四川大学 2022-06-23 — — WO claimed
WO-2022115400-A1 ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES AMGEN INC. (US) 2022-06-02 — — WO claimed
CN-114423764-A Intermediate, preparation method and application thereof 四川大学 2022-04-29 — — CN claimed
US-20220033365-A1 PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST Química Sintética, S.A. (ES) 2022-02-03 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002400-A1 ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES MCL1, BAK1, BCL2A1 CYP2A6 2071/4885CYP1A2 860/4885MAPT 3468/4885
US-20220033365-A1 PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST S1PR1, S1PR4, S1PR3 CYP2A6 2431/4885CYP1A2 2588/4885MAPT 3610/4885
US-20240279248-A1 SYNTHESIS OF BORONATE ESTER DERIVATIVES AND USES THEREOF ADH5, ADH1A, ADH7 CYP2A6 82/4885CYP1A2 99/4885MAPT 4170/4885
US-11465977-B2 Process for the preparation of sphingosine-1-phosphate receptor agonist S1PR1, S1PR4, S1PR3 CYP2A6 2431/4885CYP1A2 2588/4885MAPT 3610/4885
US-20240228437-A1 METHOD FOR PRODUCING PYRROLIDINE COMPOUND PAH, SPR, IL4I1 CYP2A6 1119/4885CYP1A2 441/4885MAPT 2511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.